nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—Raised liver function tests—Hydrochlorothiazide—nephrolithiasis	0.0472	0.0484	CcSEcCtD
Nabumetone—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0326	0.0334	CcSEcCtD
Nabumetone—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0323	0.0331	CcSEcCtD
Nabumetone—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0285	0.0292	CcSEcCtD
Nabumetone—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.0248	0.0254	CcSEcCtD
Nabumetone—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0235	0.0241	CcSEcCtD
Nabumetone—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0223	0.0229	CcSEcCtD
Nabumetone—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0222	0.0228	CcSEcCtD
Nabumetone—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0205	0.021	CcSEcCtD
Nabumetone—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.018	0.0185	CcSEcCtD
Nabumetone—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0179	0.0183	CcSEcCtD
Nabumetone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0173	CcSEcCtD
Nabumetone—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0158	0.0162	CcSEcCtD
Nabumetone—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0146	0.015	CcSEcCtD
Nabumetone—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0148	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0146	CcSEcCtD
Nabumetone—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.014	0.0144	CcSEcCtD
Nabumetone—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0137	0.014	CcSEcCtD
Nabumetone—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0138	CcSEcCtD
Nabumetone—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0137	CcSEcCtD
Nabumetone—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0131	CcSEcCtD
Nabumetone—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0129	CcSEcCtD
Nabumetone—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0128	CcSEcCtD
Nabumetone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0128	CcSEcCtD
Nabumetone—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0127	CcSEcCtD
Nabumetone—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0126	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0124	CcSEcCtD
Nabumetone—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.012	0.0123	CcSEcCtD
Nabumetone—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.012	0.0123	CcSEcCtD
Nabumetone—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.012	0.0123	CcSEcCtD
Nabumetone—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0122	CcSEcCtD
Nabumetone—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0119	CcSEcCtD
Nabumetone—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0117	CcSEcCtD
Nabumetone—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0108	CcSEcCtD
Nabumetone—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0106	CcSEcCtD
Nabumetone—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0105	CcSEcCtD
Nabumetone—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00978	0.01	CcSEcCtD
Nabumetone—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00968	0.00992	CcSEcCtD
Nabumetone—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00939	0.00963	CcSEcCtD
Nabumetone—Tension—Hydrochlorothiazide—nephrolithiasis	0.00935	0.00959	CcSEcCtD
Nabumetone—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00926	0.00949	CcSEcCtD
Nabumetone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00893	0.00916	CcSEcCtD
Nabumetone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00884	0.00907	CcSEcCtD
Nabumetone—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00881	0.00903	CcSEcCtD
Nabumetone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00876	0.00898	CcSEcCtD
Nabumetone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00871	0.00893	CcSEcCtD
Nabumetone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0086	0.00881	CcSEcCtD
Nabumetone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00856	0.00878	CcSEcCtD
Nabumetone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00855	0.00876	CcSEcCtD
Nabumetone—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00853	0.00875	CcSEcCtD
Nabumetone—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00842	0.00864	CcSEcCtD
Nabumetone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00838	0.00859	CcSEcCtD
Nabumetone—Cough—Hydrochlorothiazide—nephrolithiasis	0.00832	0.00853	CcSEcCtD
Nabumetone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00809	0.00829	CcSEcCtD
Nabumetone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00802	0.00822	CcSEcCtD
Nabumetone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00794	0.00814	CcSEcCtD
Nabumetone—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00784	0.00804	CcSEcCtD
Nabumetone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00778	0.00798	CcSEcCtD
Nabumetone—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00778	0.00798	CcSEcCtD
Nabumetone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00765	0.00785	CcSEcCtD
Nabumetone—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00762	0.00781	CcSEcCtD
Nabumetone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00752	0.00771	CcSEcCtD
Nabumetone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00742	0.0076	CcSEcCtD
Nabumetone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00704	0.00721	CcSEcCtD
Nabumetone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00699	0.00716	CcSEcCtD
Nabumetone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00694	0.00711	CcSEcCtD
Nabumetone—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00692	0.00709	CcSEcCtD
Nabumetone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00685	0.00702	CcSEcCtD
Nabumetone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00676	0.00693	CcSEcCtD
Nabumetone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00671	0.00688	CcSEcCtD
Nabumetone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00665	0.00682	CcSEcCtD
Nabumetone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00641	0.00657	CcSEcCtD
Nabumetone—PTGS2—nephron—nephrolithiasis	0.00641	0.26	CbGeAlD
Nabumetone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00636	0.00652	CcSEcCtD
Nabumetone—CYP1A2—urine—nephrolithiasis	0.0062	0.252	CbGeAlD
Nabumetone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00618	0.00634	CcSEcCtD
Nabumetone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00615	0.00631	CcSEcCtD
Nabumetone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00615	0.00631	CcSEcCtD
Nabumetone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00588	CcSEcCtD
Nabumetone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00558	0.00572	CcSEcCtD
Nabumetone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0055	0.00564	CcSEcCtD
Nabumetone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00532	0.00546	CcSEcCtD
Nabumetone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00527	CcSEcCtD
Nabumetone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00495	0.00507	CcSEcCtD
Nabumetone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00491	0.00503	CcSEcCtD
Nabumetone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0049	0.00502	CcSEcCtD
Nabumetone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00487	0.005	CcSEcCtD
Nabumetone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00462	0.00474	CcSEcCtD
Nabumetone—MPO—renal system—nephrolithiasis	0.00277	0.113	CbGeAlD
Nabumetone—MPO—kidney—nephrolithiasis	0.00268	0.109	CbGeAlD
Nabumetone—CYP1A2—renal system—nephrolithiasis	0.00152	0.0616	CbGeAlD
Nabumetone—PTGS1—renal system—nephrolithiasis	0.00132	0.0534	CbGeAlD
Nabumetone—PTGS1—kidney—nephrolithiasis	0.00127	0.0516	CbGeAlD
Nabumetone—PTGS2—renal system—nephrolithiasis	0.00126	0.051	CbGeAlD
Nabumetone—PTGS2—kidney—nephrolithiasis	0.00122	0.0493	CbGeAlD
